Myelin-oligodendrocyte glycoprotein antibody-associated disease - 19/08/21
Doi : 10.1016/S1474-4422(21)00218-0
Romain Marignier, ProfMD a, b, c, †, ⁎ 
, Yael Hacohen, MD d, †, Alvaro Cobo-Calvo, MD e, †, Anne-Katrin Pröbstel, MD f, †, Orhan Aktas, ProfMD g, Harry Alexopoulos, Dphil h, Maria-Pia Amato, ProfMD i, Nasrin Asgari, ProfMD j, Brenda Banwell, ProfMD k, l, Jeffrey Bennett, ProfMD m, Fabienne Brilot, MD n, Marco Capobianco, MD o, Tanuja Chitnis, ProfMD p, Olga Ciccarelli, ProfMD d, Kumaran Deiva, ProfMD q, Jérôme De Sèze, ProfMD r, Kazuo Fujihara, ProfMD s, t, Anu Jacob, MD u, v, Ho Jin Kim, ProfMD vv, Ingo Kleiter, ProfMD w, x, Hans Lassmann, ProfPhD y, Maria-Isabel Leite, MD z, Christopher Linington, ProfPhD aa, Edgar Meinl, ProfMD ab, Jacqueline Palace, ProfMD z, Friedemann Paul, ProfMD ad, Axel Petzold, ProfMD ae, af, ag, Sean Pittock, ProfMD ah, Markus Reindl, ProfPhD ai, Douglas Kazutoshi Sato, ProfMD aj, Krzysztof Selmaj, ProfMD ak, al, Aksel Siva, ProfMD am, Bruno Stankoff, ProfMD an, Mar Tintore, ProfMD e, Anthony Traboulsee, ProfMD ao, Patrick Waters, PhD z, Emmanuelle Waubant, ProfMD ap, Brian Weinshenker, ProfMD aq, Tobias Derfuss, ProfMD f, †, Sandra Vukusic, ProfMD a, b, c, †, Bernhard Hemmer, Prof ar, as, †
, Yael Hacohen, MD d, †, Alvaro Cobo-Calvo, MD e, †, Anne-Katrin Pröbstel, MD f, †, Orhan Aktas, ProfMD g, Harry Alexopoulos, Dphil h, Maria-Pia Amato, ProfMD i, Nasrin Asgari, ProfMD j, Brenda Banwell, ProfMD k, l, Jeffrey Bennett, ProfMD m, Fabienne Brilot, MD n, Marco Capobianco, MD o, Tanuja Chitnis, ProfMD p, Olga Ciccarelli, ProfMD d, Kumaran Deiva, ProfMD q, Jérôme De Sèze, ProfMD r, Kazuo Fujihara, ProfMD s, t, Anu Jacob, MD u, v, Ho Jin Kim, ProfMD vv, Ingo Kleiter, ProfMD w, x, Hans Lassmann, ProfPhD y, Maria-Isabel Leite, MD z, Christopher Linington, ProfPhD aa, Edgar Meinl, ProfMD ab, Jacqueline Palace, ProfMD z, Friedemann Paul, ProfMD ad, Axel Petzold, ProfMD ae, af, ag, Sean Pittock, ProfMD ah, Markus Reindl, ProfPhD ai, Douglas Kazutoshi Sato, ProfMD aj, Krzysztof Selmaj, ProfMD ak, al, Aksel Siva, ProfMD am, Bruno Stankoff, ProfMD an, Mar Tintore, ProfMD e, Anthony Traboulsee, ProfMD ao, Patrick Waters, PhD z, Emmanuelle Waubant, ProfMD ap, Brian Weinshenker, ProfMD aq, Tobias Derfuss, ProfMD f, †, Sandra Vukusic, ProfMD a, b, c, †, Bernhard Hemmer, Prof ar, as, † a Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, and Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle, Hôpital Neurologique Pierre Wertheimer, Bron, France
b Centre des Neurosciences de Lyon, INSERM 1028 et CNRS UMR5292, Lyon, France
c Université Claude Bernard Lyon 1, Lyon, France
d Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK
e Centre d’Esclerosi Múltiple de Catalunya, Department of Neurology/Neuroimmunology, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
f Neurologic Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine, Biomedicine, and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland
g Medical Faculty, Department of Neurology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
h Neuroimmunology Unit, Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece
i IRCCS Fondazione Don Carlo Gnocchi, University of Florence, Florence, Italy
j Institute of Regional Health Research and Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
k Division of Child Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
l Department of Neurology and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
m Department of Neurology and Department of Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
n Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children’s Hospital at Westmead, Brain and Mind Centre and School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
o Regional Multiple Sclerosis Centre, Department of Neurology, University Hospital San Luigi, Orbassano, Italy
p Department of Pediatric Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
q Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Hôpital Bicêtre, Pediatric Neurology Department, National Referral Center for Rare Inflammatory Brain and Spinal Diseases, Université Paris-Sud, and UMR 1184-CEA-IDMIT, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin Bicêtre, France
r Department of Neurology, Strasbourg University Hospital and Clinical Investigation Center, INSERM 1434, Strasbourg, France
s Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine Koriyama, Japan
t Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Koriyama, Japan
u Division of Multiple Sclerosis and Autoimmune Neurology, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
v Walton Centre National Health Service Trust, Liverpool, UK
vv Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea
w Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, Germany
x Department of Neurology, Ruhr-University Bochum, Bochum, Germany
y Department of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria
z Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK
aa Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK
ab Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig Maximilian University Munich, Germany
ad NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, and Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany
ae Moorfields Eye Hospital and National Hospital for Neurology and Neurosurgery, London, UK
af University College London Queen Square Institute of Neurology, London, UK
ag National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, UK
ah Department of Neurology and Laboratory Medicine and Pathology, and Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA
ai Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
aj Brain Institute of Rio Grande do Sul and School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil
ak University of Warmia and Mazury, Olsztyn, Poland
al Center of Neurology, Łódź, Poland
am Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine, Department of Neurology, Istanbul, Turkey
an Sorbonne Université, Paris Brain Institute, ICM, CNRS, Inserm, and Saint Antoine Hospital, APHP, Paris, France
ao Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
ap Department of Neurology, University of California San Francisco, San Francisco, CA, USA
aq Department of Neurology and Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA
ar Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
as Munich Cluster for Systems Neurology, Munich, Germany
* Correspondence to: Prof Romain Marignier, Service de neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, 69677 Bron, France Service de neurologie Sclérose en Plaques Pathologies de la Myéline et Neuro-inflammation Hôpital Neurologique Pierre Wertheimer Bron 69677 France
Summary |
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently identified autoimmune disorder that presents in both adults and children as CNS demyelination. Although there are clinical phenotypic overlaps between MOGAD, multiple sclerosis, and aquaporin-4 antibody-associated neuromyelitis optica spectrum disorder (NMOSD) cumulative biological, clinical, and pathological evidence discriminates between these conditions. Patients should not be diagnosed with multiple sclerosis or NMOSD if they have anti-MOG antibodies in their serum. However, many questions related to the clinical characterisation of MOGAD and pathogenetic role of MOG antibodies are still unanswered. Furthermore, therapy is mainly based on standard protocols for aquaporin-4 antibody-associated NMOSD and multiple sclerosis, and more evidence is needed regarding how and when to treat patients with MOGAD.
Le texte complet de cet article est disponible en PDF.Plan
© 2021
Elsevier Ltd. Tous droits réservés.
Vol 20 - N° 9
P. 762-772 - septembre 2021 Retour au numéro
Article précédent
- Post-viral effects of COVID-19 in the olfactory system and their implications
- Michael S Xydakis, Mark W Albers, Eric H Holbrook, Dina M Lyon, Robert Y Shih, Johannes A Frasnelli, Axel Pagenstecher, Alexandra Kupke, Lynn W Enquist, Stanley Perlman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?